Final Analysis of the LEA Study - Dr. Sibylle Loibl

Description: For more updates visit

Dr. Sibylle Loibl with an update on ECC 2013 Abstract #1851. A phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer - final analysis LEA study
Shared By : oncologyeducation
Posted on : 10/07/13
Added : 4 years ago
Category : Breast Cancer

More From oncologyeducation

Nothing found.